#LicensingDeal
LightNews LightNews
ppc.land
Udio settles copyright lawsuit, partners with Universal Music Group #Udio #CopyrightLawsuit #UniversalMusicGroup #MusicIndustry #LicensingDeal
Udio settles copyright lawsuit, partners with Universal Music Group
Udio disables downloads as part of licensing deal with Universal Music Group, settling copyright infringement litigation through industry-first agreements.
ppc.land
October 30, 2025 at 9:09 PM
marketingnews.bsky.social
Udio settles copyright lawsuit, partners with Universal Music Group #Udio #CopyrightLawsuit #UniversalMusicGroup #MusicIndustry #LicensingDeal
Udio settles copyright lawsuit, partners with Universal Music Group
Udio disables downloads as part of licensing deal with Universal Music Group, settling copyright infringement litigation through industry-first agreements.
ppc.land
October 30, 2025 at 9:09 PM
pharmaphorum.bsky.social
In its third big #licensingdeal of the week, #EliLilly has tapped into #AscidianTherapeutics' #RNAediting capabilities with a $1.9 billion #collaboration focused on #kidneydiseases.

pharmaphorum.com/news/lilly-s...
Lilly strikes $1.9bn kidney disease alliance with Ascidian
In its third big licensing deal of the week, Eli Lilly has tapped RNA-editing specialist Ascidian for kidney disease therapies in a $1.9bn alliance.
pharmaphorum.com
June 3, 2026 at 3:31 PM
pharmaphorum.bsky.social
#Servier has signed the largest #licensingdeal in its history, paying $1.55 billion upfront for #EdgewiseTherapeutics' #musculardystrophy business, headed by late-stage therapy #sevasemten.

pharmaphorum.com/news/servier...
Servier wagers $2.65bn on Edgewise muscular dystrophy drug
Servier has signed the largest licensing deal in its history, paying $1.55bn upfront for Edgewise's muscular dystrophy business headed by sevasemten.
pharmaphorum.com
June 2, 2026 at 9:17 AM
pharmaphorum.bsky.social
NEWS: #SpruceBiosciences' future was in doubt when it dropped its lead drug for congenital adrenal hyperplasia in December, but has now charted a way forward – thanks to a #licensingdeal with #BioMarin.

pharmaphorum.com/news/spruce-...
Spruce Bio sows the seeds of its new future
Spruce has bounced back from the failure of its lead drug last year, thanks to a licensing deal with BioMarin for a late-stage Sanfilippo drug.
pharmaphorum.com
April 17, 2025 at 9:32 AM
profittradingusa.bsky.social
Click Subscribe #Biotech #VorBiopharma #Aktienmarkt #LicensingDeal #Autoimmuntherapie
www.investing.com
June 26, 2025 at 1:53 PM
trendingstocks.bsky.social
AI Licensing: A Gamble? - All-In Pod

#openai #licensingdeal #licensing #copyright #ai
July 1, 2025 at 8:42 PM